Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-044669
Filing Date
2018-08-01
Accepted
2018-08-01 12:53:07
Documents
1
Period of Report
2018-07-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9151
  Complete submission text file 0001209191-18-044669.txt   10536
Mailing Address 735 BROAD ST STE 1105 CHATTANOOGA TN 37402
Business Address
MCKENZIE W THORPE (Reporting) CIK: 0001211462 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37347 | Film No.: 18983914

Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations